A phase 4 study of formoterol fumarate showed similar safety performance as placebo in patients with moderate-to-severe chronic obstructive pulmonary disease, according to a recently published study.

Barcelona, September, 25 2014. - Almirall S.A. (ALM) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion ...

Asthma inhaler Patients with COPD who received a metered dose inhaler containing budesonide, glycopyrrolate, and formoterol fumarate showed lung function improvements through 52 weeks. This article is ...

The trial met its primary endpoint demonstrating that PT010 reduced the rate of moderate or severe COPD exacerbations by 24% compared with PT003 (rate ratio, 0.76; 95% confidence interval [CI], 0.69–0 ...

Learn everything you need to know about Mometasone Furoate and Formoterol Fumarate-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side ...

FDA Approves Merck's DULERA(R) (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol for the Treatment of Asthma in Patients 12 Years of Age and Older WHITEHOUSE STATION, N.J., Jun ...

(Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO) SYMBICORT is a combination asthma medication that contains both an inhaled corticosteroid (ICS ...

WILMINGTON, Del.--(BUSINESS WIRE)--Full results from the positive Phase III ETHOS trial showed AstraZeneca’s triple-combination therapy PT010 (budesonide ...

Details concerning the Formoterol Fumarate combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, ...

BEVESPI AEROSPHERE (glycopyrronium bromide/formoterol fumarate) accepted for use in NHS Scotland for adult patients with chronic pulmonary respiratory disease (COPD) BY THE SCOTTISH MEDICINES ...

Merck announced results from two Phase 3 studies investigating fixed-dose combinations of mometasone furoate and formoterol fumarate (MF/F) for the management of asthma, for which a New Drug ...

PITTSBURGH, PA and WOODBURY, MN / ACCESSWIRE / July 31, 2023 / Viatris Inc. (NASDAQ:VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ ...